Methods: Between November 2011 and June 2012, 60 patients who received temporary femoral hemodialysis catheter in our clinic were prospectively analyzed. The patients were divided into two groups according to serum albumin level higher than 3 g/dL (group 1, n=30) and serum albumin level lower than 3 g/dL (group 2, n=30) patients. All patients underwent temporary femoral hemodialysis catheter implantation with the guidance of ultrasonography under local anesthesia in the cardiovascular operating room.
Results: Of these chronic renal failure patients, three previously received radiation therapy; 12 patients had diabetes mellitus, 13 patients had morbid obesity, 23 patients had hypertension and 19 patients had chronic obstructive pulmonary disease. The demographic characteristics of group 1 and group 2 were similar. The incidence of deep venous trombosis was three patients (10%) in group 1 and 10 patients (33%) in group 2 (p=0.037). There was a statistically significant correlation between low serum albumin level and risk for deep venous thrombosis in temporary femoral hemodialysis catheter inserted patients.
Conclusion: Prophylactic anticoagulation should be considered in patients who are scheduled for a temporary femoral hemodialysis catheter with a low serum albumin level.